News Detail
Shimla, 22 Nov 2024: Himachal Pradesh High Court on Thursday disposed of a petition that alleged spurious and substandard drugs were being manufactured by many pharma units in Baddi and directed the Drugs Controller to decide the complaint within two weeks. View Details
Source : PTI
Himachal Pradesh High Court
Drugs Controller
Themis Medicare Limited
spurious drugs
Feracrylum API
Related News
- Illegal cough syrup worth Rs 5 Crore seized at Assam-Tripura border (08-12-2024)
- Tragedy at Hyderabad Pharma: NGT Orders Accountability (08-12-2024)
- Experts Call for Urgent Standardisation and Quality Control of Herbal Medicines (08-12-2024)
- Experts Warn Against OTC Creams for Skin Issues: Potential Harm from Steroid Use (08-12-2024)
- Expert team will probe maternal deaths in Ballari hospital: Health Minister (08-12-2024)
- Maha FDA finds spurious drugs at rural GMCH in Beed, FIR against 4 suppliers (08-12-2024)
- CDSCO waives local clinical trials for new drugs approved in the USA, UK, Japan, Australia, Canada and EU: Govt in LS (07-12-2024)
- NDPS Act: SC explains law on presence of gazetted officer during search (07-12-2024)
- Contraband cough syrup seized from Tejas Rajdhani express (07-12-2024)
- Government has taken several measures to encourage domestic manufacturing: Govt in LS (07-12-2024)